Option Care Health, Inc. (NASDAQ:OPCH) Given Average Rating of "Moderate Buy" by Analysts

Key Points

• Moderate Buy consensus from 11 analysts (8 buy, 2 hold, 1 strong buy) with an average 1‑year price target of $37.27.
• Q4 results showed EPS of $0.46 meeting estimates and revenue of $1.47B slightly above expectations, with revenue up 8.8% year‑over‑year and analysts forecasting $1.22 EPS for the current year.
• The stock trades around $29 with a market cap of $4.55B, a P/E of 22.66 and a 52‑week range of $24.24–$36.80, and institutional investors own about 98% of the shares.

Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) has been given an average recommendation of "Moderate Buy" by the eleven ratings firms that are covering the stock, MarketBeat reports. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating on the company. The average 1 year price objective among brokers that have covered the stock in the last year is $37.2727.

A number of brokerages have weighed in on OPCH. Barrington Research lifted their price target on shares of Option Care Health from $38.00 to $42.00 and gave the company an "outperform" rating in a report on Friday, January 16th. Jefferies Financial Group reiterated a "buy" rating and issued a $37.00 price target on shares of Option Care Health in a report on Tuesday, January 13th. Morgan Stanley lifted their price target on shares of Option Care Health from $35.00 to $38.00 and gave the company an "overweight" rating in a report on Tuesday, January 13th. Citigroup restated an "outperform" rating on shares of Option Care Health in a report on Tuesday, January 13th. Finally, Citizens Jmp restated a "market outperform" rating and set a $38.00 target price (up from $36.00) on shares of Option Care Health in a report on Tuesday, January 13th.

Option Care Health Price Performance

Shares of OPCH opened at $29.00 on Monday. The firm has a market cap of $4.55 billion, a PE ratio of 22.66, a price-to-earnings-growth ratio of 1.62 and a beta of 0.95. The company's fifty day moving average is $31.07 and its two-hundred day moving average is $30.70. Option Care Health has a fifty-two week low of $24.24 and a fifty-two week high of $36.80. The company has a quick ratio of 0.96, a current ratio of 1.53 and a debt-to-equity ratio of 0.87.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings results on Tuesday, February 24th. The company reported $0.46 earnings per share for the quarter, meeting analysts' consensus estimates of $0.46. The company had revenue of $1.47 billion for the quarter, compared to analyst estimates of $1.46 billion. Option Care Health had a net margin of 3.67% and a return on equity of 18.57%. Option Care Health's revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter last year, the business earned $0.44 EPS. Analysts forecast that Option Care Health will post 1.22 earnings per share for the current year.

Hedge Funds Weigh In On Option Care Health

Hedge funds and other institutional investors have recently made changes to their positions in the business. V Square Quantitative Management LLC acquired a new position in shares of Option Care Health during the 4th quarter valued at $25,000. Cornerstone Planning Group LLC increased its stake in Option Care Health by 7,621.4% during the 3rd quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company's stock worth $30,000 after buying an additional 1,067 shares during the period. Advisory Services Network LLC purchased a new stake in Option Care Health during the 3rd quarter worth $35,000. McIlrath & Eck LLC acquired a new stake in shares of Option Care Health during the second quarter valued at about $37,000. Finally, Caitong International Asset Management Co. Ltd acquired a new stake in shares of Option Care Health during the third quarter valued at about $38,000. Institutional investors and hedge funds own 98.05% of the company's stock.

About Option Care Health

Option Care Health NASDAQ: OPCH is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry's most experienced home infusion businesses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.